Evidence map›Paper›PMID 36444867›Full record

ArticleJournal of the American Heart Association2022

Integrin α7 Mutations Are Associated With Adult-Onset Cardiac Dysfunction in Humans and Mice.

Enrico Bugiardini, Andreia M Nunes, Ariany Oliveira-Santos, Marisela Dagda, Tatiana M Fontelonga, Pamela Barraza-Flores, Alan M Pittman, Jasper M Morrow, Matthew Parton, Henry Houlden and 14 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the American Heart Association, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Integrin Signaling Pathways in Aortic Aneurysm and Dissection.Reviews in cardiovascular medicine · 2026
    Review
  3. Decoding the Heart Failure Peptidome.Circulation. Heart failure · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 8 institutions in 4 countries.

Enrico BugiardiniQueen Square Centre for Neuromuscular Diseases Queen Square Institute of Neurology, UCL and National Hospital for Neurology and Neurosurgery London United Kingdom.ORCID 0000-0002-9709-6699
Andreia M NunesDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.ORCID 0000-0001-9996-013X
Ariany Oliveira-SantosDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.ORCID 0000-0002-6141-0148
Marisela DagdaDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.
Tatiana M FontelongaDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.ORCID 0000-0001-9947-0317
Pamela Barraza-FloresDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.
Alan M PittmanDepartment of Neuromuscular Diseases UCL Queen Square Institute of Neurology London United Kingdom.ORCID 0000-0002-8112-2987
Jasper M MorrowQueen Square Centre for Neuromuscular Diseases Queen Square Institute of Neurology, UCL and National Hospital for Neurology and Neurosurgery London United Kingdom.
Matthew PartonQueen Square Centre for Neuromuscular Diseases Queen Square Institute of Neurology, UCL and National Hospital for Neurology and Neurosurgery London United Kingdom.ORCID 0000-0001-6076-668X
Henry HouldenDepartment of Neuromuscular Diseases UCL Queen Square Institute of Neurology London United Kingdom.ORCID 0000-0002-2866-7777
Perry M ElliottBarts Heart Centre, Barts Health NHS Trust London United Kingdom.ORCID 0000-0003-3383-3984
Petros SyrrisCentre for Heart Muscle Disease Institute of Cardiovascular Science, University College London London United Kingdom.ORCID 0000-0002-2363-8758
Roderick P MaasDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour Radboud University Medical Center Nijmegen The Netherlands.ORCID 0000-0003-0823-1287
Mohammed M AkhtarBarts Heart Centre, Barts Health NHS Trust London United Kingdom.ORCID 0000-0003-3447-6376
Benno KüstersDepartment of Pathology Radboud University Medical Center Nijmegen The Netherlands.ORCID 0000-0003-0458-9441
Joost RaaphorstDepartment of Neurology, Amsterdam University Medical Centre, University of Amsterdam, Amsterdam Neuroscience Amsterdam The Netherlands.ORCID 0000-0002-3658-2001
Meyke SchoutenDepartment of Human Genetics Radboud University Medical Center Nijmegen The Netherlands.ORCID 0000-0002-7763-8956
Erik-Jan KamsteegDepartment of Human Genetics Radboud University Medical Center Nijmegen The Netherlands.
Baziel van EngelenDepartment of Neurology, Donders Institute for Brain, Cognition and Behaviour Radboud University Medical Center Nijmegen The Netherlands.ORCID 0000-0001-9867-9047
Michael G HannaQueen Square Centre for Neuromuscular Diseases Queen Square Institute of Neurology, UCL and National Hospital for Neurology and Neurosurgery London United Kingdom.ORCID 0000-0003-0825-4075
Rahul PhadkeDivision of Neuropathology UCL Institute of Neurology London United Kingdom.ORCID 0000-0001-9699-2718
Luis R LopesBarts Heart Centre, Barts Health NHS Trust London United Kingdom.ORCID 0000-0002-6408-4667
Emma MatthewsThe Atkinson Morley Neuromuscular Centre and Regional Neurosciences Centre St George's University Hospitals NHS Foundation Trust London United Kingdom.ORCID 0000-0002-3810-306X
Dean J BurkinDepartment of Pharmacology University of Nevada Reno, School of Medicine, Center for Molecular Medicine Reno NV.ORCID 0000-0001-9228-5258
University of Nevada, Reno · USNational Hospital for Neurology and Neurosurgery · GBRadboud University Nijmegen · NLBarts Health NHS Trust · GBSt George's, University of London · GBAmsterdam Neuroscience · NLGreat Ormond Street Hospital · GBUniversity College London · GB

Funding

Laminin protein therapy for Congenital Muscular DystrophyR01AR064338 · NIAMS · UNIVERSITY OF NEVADA RENO · PI BURKIN, DEAN J. · 2014 to 2018
$1.6M
Optimization of an integrin enhancing molecule for the treatment of Duchenne muscular dystrophyR42OD030543 · OD · STRYKAGEN CORPORATION · PI BURKIN, DEAN J. · 2020 to 2021
$1.5M
Integrin Alleviation of Muscular DystrophyR01AR053697 · NIAMS · UNIVERSITY OF NEVADA RENO · PI BURKIN, DEAN J. · 2008 to 2012
$1.2M
Department of HealthMedical Research Council MR/T005181/1Medical Research Council MR/V037838/1NIAMS NIH HHS R01 AR053697NIAMS NIH HHS R01 AR064338NIH HHS R42 OD030543Wellcome Trust
6 · The paper itself

Abstract

Background Integrin α7β1 is a major laminin receptor in skeletal and cardiac muscle. In skeletal muscle, integrin α7β1 plays an important role during muscle development and has been described as an important modifier of skeletal muscle diseases. The integrin α7β1 is also highly expressed in the heart, but its precise role in cardiac function is unknown. Mutations in the integrin α7 gene (

Indexed as

Heart DiseasesMuscular DiseasesAdultAnimalsAntigens, CDChildFamilyHumansIntegrin alpha ChainsMiceAntigens, CDintegrin alpha7Integrin alpha Chainscardiomyopathycongenital muscular dystrophycongenital myopathyintegrin α7

Identifiers

PMID36444867
PMCPMC9851448
OpenAlexW4310239173

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.